Annual CFO
$126.22 M
-$409.75 M-76.45%
31 December 2023
Summary:
Maravai LifeSciences Holdings annual cash flow from operations is currently $126.22 million, with the most recent change of -$409.75 million (-76.45%) on 31 December 2023. During the last 3 years, it has fallen by -$25.96 million (-17.06%). MRVI annual CFO is now -76.45% below its all-time high of $535.98 million, reached on 31 December 2022.MRVI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$13.14 M
-$4.30 M-24.65%
30 September 2024
Summary:
Maravai LifeSciences Holdings quarterly cash flow from operations is currently $13.14 million, with the most recent change of -$4.30 million (-24.65%) on 30 September 2024. Over the past year, it has dropped by -$1.03 million (-7.27%). MRVI quarterly CFO is now -92.08% below its all-time high of $165.94 million, reached on 30 June 2021.MRVI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$29.89 M
-$1.03 M-3.33%
30 September 2024
Summary:
Maravai LifeSciences Holdings TTM cash flow from operations is currently $29.89 million, with the most recent change of -$1.03 million (-3.33%) on 30 September 2024. Over the past year, it has dropped by -$187.88 million (-86.27%). MRVI TTM CFO is now -94.42% below its all-time high of $535.98 million, reached on 31 December 2022.MRVI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRVI Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.5% | -7.3% | -86.3% |
| 3 y3 years | -17.1% | -87.6% | -92.3% |
| 5 y5 years | +10000.0% | - | - |
MRVI Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -76.5% | at low | -92.0% | +255.1% | -94.4% | at low |
| 5 y | 5 years | -76.5% | >+9999.0% | -92.1% | +255.1% | -94.4% | +207.8% |
| alltime | all time | -76.5% | >+9999.0% | -92.1% | +255.1% | -94.4% | +207.8% |
Maravai LifeSciences Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.14 M(-24.7%) | $29.89 M(-3.3%) |
| June 2024 | - | $17.43 M(-305.9%) | $30.92 M(-5.4%) |
| Mar 2024 | - | -$8.47 M(-208.7%) | $32.68 M(-74.1%) |
| Dec 2023 | $126.22 M(-76.4%) | $7.79 M(-45.0%) | $126.22 M(-42.0%) |
| Sept 2023 | - | $14.17 M(-26.2%) | $217.77 M(-30.6%) |
| June 2023 | - | $19.19 M(-77.4%) | $313.66 M(-31.6%) |
| Mar 2023 | - | $85.07 M(-14.4%) | $458.75 M(-14.4%) |
| Dec 2022 | $535.98 M | $99.33 M(-9.7%) | $535.98 M(+8.2%) |
| Sept 2022 | - | $110.06 M(-33.0%) | $495.38 M(+0.9%) |
| June 2022 | - | $164.28 M(+1.2%) | $490.89 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $162.30 M(+176.3%) | $492.55 M(+33.6%) |
| Dec 2021 | $368.57 M(+142.2%) | $58.74 M(-44.4%) | $368.57 M(-5.3%) |
| Sept 2021 | - | $105.56 M(-36.4%) | $389.26 M(+16.2%) |
| June 2021 | - | $165.94 M(+333.0%) | $335.12 M(+85.4%) |
| Mar 2021 | - | $38.33 M(-51.7%) | $180.80 M(+18.8%) |
| Dec 2020 | $152.19 M(+531.1%) | $79.43 M(+54.5%) | $152.19 M(+109.2%) |
| Sept 2020 | - | $51.43 M(+342.8%) | $72.76 M(+241.1%) |
| June 2020 | - | $11.62 M(+19.6%) | $21.33 M(+119.6%) |
| Mar 2020 | - | $9.71 M | $9.71 M |
| Dec 2019 | $24.11 M(<-9900.0%) | - | - |
| Dec 2018 | -$186.00 K | - | - |
FAQ
- What is Maravai LifeSciences Holdings annual cash flow from operations?
- What is the all time high annual CFO for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual CFO year-on-year change?
- What is Maravai LifeSciences Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly CFO year-on-year change?
- What is Maravai LifeSciences Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings TTM CFO year-on-year change?
What is Maravai LifeSciences Holdings annual cash flow from operations?
The current annual CFO of MRVI is $126.22 M
What is the all time high annual CFO for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual cash flow from operations is $535.98 M
What is Maravai LifeSciences Holdings annual CFO year-on-year change?
Over the past year, MRVI annual cash flow from operations has changed by -$409.75 M (-76.45%)
What is Maravai LifeSciences Holdings quarterly cash flow from operations?
The current quarterly CFO of MRVI is $13.14 M
What is the all time high quarterly CFO for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly cash flow from operations is $165.94 M
What is Maravai LifeSciences Holdings quarterly CFO year-on-year change?
Over the past year, MRVI quarterly cash flow from operations has changed by -$1.03 M (-7.27%)
What is Maravai LifeSciences Holdings TTM cash flow from operations?
The current TTM CFO of MRVI is $29.89 M
What is the all time high TTM CFO for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high TTM cash flow from operations is $535.98 M
What is Maravai LifeSciences Holdings TTM CFO year-on-year change?
Over the past year, MRVI TTM cash flow from operations has changed by -$187.88 M (-86.27%)